UDGEE Hospital S.Maria Nuova
Reggio Emilia, RE, 42100, Italy
NCT Number: NCT00961103
Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood.
According to the age of onset and the maximum motor function the disorder is classified in 4 types. Patients with SMA II and SMA III often use orthoses to achieve postural and dynamic functions.
In this retrospective observational study the investigators describe the characteristics of sitting position, standing and walking correlated to type and time of orthoses used.
Looking for future studies?
Notify MeAll sexes
Observational
Reggio Emilia, RE, 42100, Italy
We collect data from patients with SMA II and SMA III referred to UDGEE from jan. 1995 to dec. 2008.
We estimate to achieve informations about 50-70 patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: aug.2009- nov.2009
Time frame: aug. 2009 - dec.2009
Azienda USL Reggio Emilia - IRCCS
Other Gov
Assessment of Motor Development Related to Use of Orthoses in SMA II and III
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05341453
Central Nervous System Diseases, Motor Neuron Disease
Prague, Czechia
View Trial DetailsNCT07547189
Central Nervous System Diseases, Communication Disorders
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT05794139
Central Nervous System Diseases, Motor Neuron Disease
Los Angeles, California, United States
View Trial DetailsNCT03689660
Biofeedback, Central Nervous System Diseases
Izmir, Balcova, Turkey (Türkiye)
View Trial Details